Insulin-producing cells (IPCs) derived from human pluripotent stem cells (hPSCs) may be useful in cell therapy and drug discovery for diabetes. effective therapies for the treatment of patients with severe diabetes1,2,3. However, the shortage of donor human pancreases limits such clinical therapy. Human pluripotent stem cells (hPSCs), including human embryonic stem cells (hESCs) and induced… Continue reading Insulin-producing cells (IPCs) derived from human pluripotent stem cells (hPSCs) may